Ball, Graham

Transferrin receptor (CD71) is a marker of poor prognosis in breast cancer and can predict response to tamoxifen

Habashy, H. O., Powe, D. G., Staka, C. M., Rakha, E. A., Ball, G., Green, A. R., Aleskandarany, M., Paish, E. C., Douglas Macmillan, R., Nicholson, R. I., et al. (2010) · Breast Cancer Research and Treatment

Breast Cancer Treatment StudiesEstrogen and related hormone effects

Cited by 236

NKG2D ligand expression in human colorectal cancer reveals associations with prognosis and evidence for immunoediting

McGilvray, R. W., Eagle, R. A., Watson, N. F. S., Al-Attar, A., Ball, G., Jafferji, I., Trowsdale, J., & Durrant, L. G. (2009) · Clinical Cancer Research

Immune Cell Function and InteractionCancer Immunotherapy and Biomarkers

Cited by 196

HAGE in Triple-Negative Breast Cancer Is a Novel Prognostic, Predictive, and Actionable Biomarker: A Transcriptomic and Protein Expression Analysis

Abdel-Fatah, T. M. A., McArdle, S. E. B., Agarwal, D., Moseley, P. M., Green, A. R., Ball, G. R., Pockley, A. G., Ellis, I. O., Rees, R. C., & Chan, S. Y. T. (2016) · Clinical Cancer Research

Breast Cancer Treatment StudiesBreast Lesions and Carcinomas

Cited by 20